Log In
Print
BCIQ
Print
Print this Print this
 

darunavir/cobicistat (Prezcobix, Rezolsta)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionFixed dose combination of darunavir and cobicistat HIV tablet
Molecular Target Cytochrome P450 family 3 subfamily A (CYP3A) (CYP3) ; HIV protease
Mechanism of ActionCytochrome P450 inhibitor; HIV protease inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentRegistration
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

Partner

Gilead Sciences Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today